B1261007: A phase 2 randomized double-blind placebo-controlled parallel group multi-centre study to evaluate the efficacy and sagety of once-daily administration of a chemokine CCR2/5 receptor antagon

Project: Research

StatusFinished
Effective start/end date1/06/1330/12/13